These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31676132)

  • 1. Mechanism of μ-Opioid Receptor-Magnesium Interaction and Positive Allosteric Modulation.
    Hu X; Provasi D; Ramsey S; Filizola M
    Biophys J; 2020 Feb; 118(4):909-921. PubMed ID: 31676132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and thermodynamic insights into sodium ion translocation through the μ-opioid receptor from molecular dynamics and machine learning analysis.
    Hu X; Wang Y; Hunkele A; Provasi D; Pasternak GW; Filizola M
    PLoS Comput Biol; 2019 Jan; 15(1):e1006689. PubMed ID: 30677023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct subtypes of the opioid receptor with allosteric interactions in brain membranes.
    Demoliou-Mason CD; Barnard EA
    J Neurochem; 1986 Apr; 46(4):1118-28. PubMed ID: 3005504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor.
    Livingston KE; Traynor JR
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18369-74. PubMed ID: 25489080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulation model of the mu opioid receptor by herkinorin, a potent not alkaloidal agonist.
    Marmolejo-Valencia AF; Martínez-Mayorga K
    J Comput Aided Mol Des; 2017 May; 31(5):467-482. PubMed ID: 28364251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed Mode of Binding and Action of Positive Allosteric Modulators at Opioid Receptors.
    Shang Y; Yeatman HR; Provasi D; Alt A; Christopoulos A; Canals M; Filizola M
    ACS Chem Biol; 2016 May; 11(5):1220-9. PubMed ID: 26841170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All atom NMDA receptor transmembrane domain model development and simulations in lipid bilayers and water.
    Mesbahi-Vasey S; Veras L; Yonkunas M; Johnson JW; Kurnikova MG
    PLoS One; 2017; 12(6):e0177686. PubMed ID: 28582391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
    Wong CS; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):317-26. PubMed ID: 1320689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways.
    Schneider S; Provasi D; Filizola M
    Biochemistry; 2016 Nov; 55(46):6456-6466. PubMed ID: 27778501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the function of opioid receptors from molecular dynamics simulations of available crystal structures.
    Marino KA; Shang Y; Filizola M
    Br J Pharmacol; 2018 Jul; 175(14):2834-2845. PubMed ID: 28266020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering a high-affinity allosteric binding site for divalent cations in kainate receptors.
    Plested AJ; Mayer ML
    Neuropharmacology; 2009 Jan; 56(1):114-20. PubMed ID: 18687343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing Ion-Binding Sites for GPCR Pharmacology.
    Zarzycka B; Zaidi SA; Roth BL; Katritch V
    Pharmacol Rev; 2019 Oct; 71(4):571-595. PubMed ID: 31551350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insights into allosteric regulation of the A
    Ye L; Neale C; Sljoka A; Lyda B; Pichugin D; Tsuchimura N; Larda ST; Pomès R; García AE; Ernst OP; Sunahara RK; Prosser RS
    Nat Commun; 2018 Apr; 9(1):1372. PubMed ID: 29636462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between Two Allosteric Sites and Their Influence on Agonist Binding in Human μ Opioid Receptor.
    Bartuzi D; Kaczor AA; Matosiuk D
    J Chem Inf Model; 2016 Mar; 56(3):563-70. PubMed ID: 26863088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanine nucleotide regulation of [125I]beta-endorphin binding to NG108-15 and SK-N-SH cell membranes: specific cation requirements.
    Selley DE; Bidlack JM
    Brain Res; 1989 Jul; 493(1):23-32. PubMed ID: 2550106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and Allosteric Modulation of Human μ Opioid Receptor in Molecular Dynamics.
    Bartuzi D; Kaczor AA; Matosiuk D
    J Chem Inf Model; 2015 Nov; 55(11):2421-34. PubMed ID: 26517559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cation and guanine nucleotide effects on ligand binding properties of mu and delta opioid receptors in rat brain membranes.
    Benyhe S; Szücs M; Varga E; Simon J; Borsodi A; Wollemann M
    Acta Biochim Biophys Hung; 1989; 24(1-2):69-81. PubMed ID: 2558475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sites of divalent cation modulation of delta opioid receptor binding.
    Szücs M; Oetting GM; Coscia CJ
    NIDA Res Monogr; 1986; 75():113-6. PubMed ID: 2828955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5'-yl imidodiphosphate.
    Wong CS; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1994 Feb; 268(2):653-61. PubMed ID: 8113975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive Binding of Mg
    Xi K; Wang FH; Xiong G; Zhang ZL; Tan ZJ
    Biophys J; 2018 Apr; 114(8):1776-1790. PubMed ID: 29694858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.